Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Iversen, Philip W.
481  Ergebnisse:
Personensuche X
?
1

Addressing Unusual Assay Variability with Robust Statistics:

Haelewyn, Jason ; Iversen, Philip W. ; Weidner, Jeffrey R.
SLAS Discovery.  26 (2021)  10 - p. 1291-1297 , 2021
Link: https://doi.org/10.1177/..
 
?
2

A pan-cancer transcriptome analysis identifies replication ..:

Blosser, Wayne D. ; Dempsey, Jack A. ; McNulty, Ann M....
Oncotarget.  11 (2020)  3 - p. 216-236 , 2020
Link: https://doi.org/10.18632..
 
?
3

Translational Framework Predicting Tumour Response in Gemci..:

Garcia-Cremades, Maria ; Pitou, Celine ; Iversen, Philip W..
The AAPS Journal.  21 (2019)  2 - p. , 2019
Link: https://doi.org/10.1208/..
 
?
4

Predicting tumour growth and its impact on survival in gemc..:

Garcia-Cremades, Maria ; Pitou, Celine ; Iversen, Philip W..
European Journal of Pharmaceutical Sciences.  115 (2018)  - p. 296-303 , 2018
Link: https://doi.org/10.1016/..
 
?
5

Assay Guidance Manual: Quantitative Biology and Pharmacolog..:

Coussens, Nathan P. ; Sittampalam, G. Sitta ; Guha, Rajarshi...
Clinical and Translational Science.  11 (2018)  5 - p. 461-470 , 2018
Link: https://doi.org/10.1111/..
 
?
6

Characterization of a novel AICARFT inhibitor which potentl..:

Brooks, Harold B. ; Meier, Timothy I. ; Geeganage, Sandaruwan...
Scientific Reports.  8 (2018)  1 - p. , 2018
Link: https://doi.org/10.1038/..
 
?
7

Targeting the TGFβ pathway with galunisertib, a TGFβRI smal..:

Holmgaard, Rikke B. ; Schaer, David A. ; Li, Yanxia...
Journal for ImmunoTherapy of Cancer.  6 (2018)  1 - p. , 2018
Link: https://doi.org/10.1186/..
 
?
8

The CDK4/6 Inhibitor Abemaciclib Induces a T Cell Inflamed ..:

Schaer, David A. ; Beckmann, Richard P. ; Dempsey, Jack A....
Cell Reports.  22 (2018)  11 - p. 2978-2994 , 2018
Link: https://doi.org/10.1016/..
 
?
9

Preclinical assessment of galunisertib (LY2157299 monohydra..:

Yingling, Jonathan M. ; McMillen, William T. ; Yan, Lei...
Oncotarget.  9 (2017)  6 - p. 6659-6677 , 2017
Link: https://doi.org/10.18632..
 
?
10

Assay Establishment and Validation of a High-Throughput Scr..:

Boehnke, Karsten ; Iversen, Philip W. ; Schumacher, Dirk...
SLAS Discovery.  21 (2016)  9 - p. 931-941 , 2016
Link: https://doi.org/10.1177/..
 
?
11

Selectivity Data: Assessment, Predictions, Concordance, and..:

Gao, Cen ; Cahya, Suntara ; Nicolaou, Christos A....
Journal of Medicinal Chemistry.  56 (2013)  17 - p. 6991-7002 , 2013
Link: https://doi.org/10.1021/..
 
?
12

Nonclinical Assessment of Carcinogenic Risk and Tumor Growt..:

Buckley, Lorrene A. ; Sanbuissho, Atsushi ; Starling, James J....
International Journal of Toxicology.  31 (2012)  4 - p. 317-325 , 2012
Link: https://doi.org/10.1177/..
 
?
13

A Comparison of Assay Performance Measures in Screening Ass..:

Iversen, Philip W. ; Eastwood, Brian J. ; Sittampalam, G. Sitta.
SLAS Discovery.  11 (2006)  3 - p. 247-252 , 2006
Link: https://doi.org/10.1177/..
 
?
14

The Minimum Significant Ratio: A Statistical Parameter to C..:

Eastwood, Brian J. ; Farmen, Mark W. ; Iversen, Philip W....
SLAS Discovery.  11 (2006)  3 - p. 253-261 , 2006
Link: https://doi.org/10.1177/..
 
?
15

Acyl Sulfonamide Anti-Proliferatives:  Benzene Substituent ..:

Lobb, Karen L. ; Hipskind, Philip A. ; Aikins, James A....
Journal of Medicinal Chemistry.  47 (2004)  22 - p. 5367-5380 , 2004
Link: https://doi.org/10.1021/..
 
1-15